arrow
Back
N

Nir Peled

hebrew university of jerusalem

75H-index
559Paper Count
4.2WCitation Count
Published Papers 160
Publication Date
Osimertinib before and after chemoradiotherapy for unresectable stage III EGFR-mutated NSCLC: NEOLA Trial Protocol
err2025-11-01
err0
PREAI
errAredo, Jacqueline V.; Peled, Nir; Arriola, Edurne; Wakelee, Heather; Ahn, Myung-Ju; Kwint, Margriet H.; Taylor, Rosemary; van der Gronde, Toon; Nasirova, Feruza; Chen, Ming
errShare
errSave
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib
err2025-09-08
err0
errOAAI
errNir Peled; Amanda Tufman; Lecia V. Sequist; Giulia Pasello; Qiming Wang; Lorenzo Antonuzzo; Jose González Larriba; Soledad Medina Valdivieso; Manuel Cobo Dols; Michele Milella; Julia Dudnik; Paloma Martín-Martorell; Isidoro Barneto Aranda; Dingzhi Huang; Noemi V. Palicio; Antonino Scimone; Emilio Bria; Leslie Servidio; Rodrigo Pimentel; Abdul-Azeez Ganiyu; Jun Zhao
errShare
errSave
Lurbinectedin for extensive stage − small cell lung cancer (ES-SCLC): real world response patterns and survival outcomes
err2025-06-02
err0
PREAI
errBelal Krayim; Walid Shalata; Jair Bar; Mor Moskovitz; Ofer Rotem; Damian Urban; Hadas Gantz Sorotsky; Waleed Kian; Ekaterina Hanovich; Ranin Marie; Shir Mann; Roni Gillis; Afifi Basel; Gleb Kornev; Noam Asna; Nir Peled; Laila C. Roisman
errShare
errSave
Lung Immune Prognostic Index-Based Predictive Score in Advanced Non-Small Cell Lung Cancer with a Programmed Death Ligand-1 Tumor Proportion Score ≥ 50%
err2025-05-19
err0
errOAAI
errRaphael, Ari; Kamm Feldman, Ayelet; Lazarev, Irina; Kian, Waleed; Peled, Nir; Hod, Keren; Shalata, Walid; Dudnik, Elizabeth
errShare
errSave
Characterization of the xeno-GVHD response generated by advanced lung cancer patient peripheral blood mononuclear cells in NSG-SGM3 mice
err2025-04-01
err0
errOAAI
errFuchs, Vered; Roisman, Laila; Msamra, Maha; Refaely, Yael; Cohen, Aharon Yehonatan; Porgador, Angel; Peled, Nir; Sobarzo, Ariel
errShare
errSave
Amivantamab as a salvage therapy post-EGFR-tyrosine kinase inhibitor failure in patients with mutated EGFR non-small cell lung cancer
err2025-03-01
err0
errOAAI
errKrayim, Bilal; Kian, Waleed; Spector, Maria; Granot, Inbal; Dudnik, Julia; Nissim, Michal; Kahala, Dolev; Remilah, Areen Abu; Bogot, Naama R.; Kornev, Gleb; Asna, Noam; Peled, Nir
errShare
errSave
Identifying Factors Associated with Disparities in Accessing an Integrative Oncology Program
err2025-03-01
err0
PREAI
errSamuels, Noah; Gressel-Raz, Orit; Peled, Nir; Stein, Nili; Granot, Inbal; Ben-Arye, Eran
errShare
errSave
Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer
err2024-11-13
err0
errOAAI
errKian, Waleed; Krayim, Belal; Giles, Betsy; Elkiaan, Nasim A.; Idris, Amjad; Fink, Daniel; Peled, Nir; Roisman, Laila C.
errShare
errSave
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer
err2024-05-15
err5
errOAAI
errMalapelle, Umberto; Leighl, Natasha; Addeo, Alfredo; Hershkovitz, Dov; Hochmair, Maximilian J.; Khorshid, Ola; Laenger, Florian; de Marinis, Filippo; Peled, Nir; Sheffield, Brandon S.; Smit, Egbert F.; Viteri, Santiago; Wolf, Juergen; Venturini, Filippo; O'Hara Jr, Richard M.; Rolfo, Christian
errShare
errSave
Results from KEYNOTE-B99: Phase 2 study of first-line (1L) pembrolizumab (pembro) plus investigational agents and chemotherapy (chemo) for extensive-stage small-cell lung cancer (ES-SCLC)
err2024-04-05
err0
PREAI
errRodriguez-Abreu, Delvys; Hochmair, Maximillian; Cho, Byoung Chul; Csoszi, Tibor; Kutiel, Talia Shentzer; Mueller, Veronika; Ahn, Myung-Ju; Kowalski, Dariusz; Maio, Michele; Moiseyenko, Vladimir; Navarro, Alejandro; Niu, Jianxin; Fung, Andrea S.; Lips, Carolin; Zhou, Heng; Zhao, Bin; Lara-Guerra, Humberto; Peled, Nir
errShare
errSave
Results from KEYMAKER-U01 substudy 3: a phase 2 umbrella study of pembrolizumab plus investigational agents in patients with non-small-cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy
err2024-04-05
err0
PREAI
errAggarwal, Charu; Stevenson, James; Kowalski, Dariusz M.; Csoszi, Tibor; Peled, Nir; Cho, Byoung Chul; Rubio-Viqueira, Belen; Niu, Jiaxin; Carbone, David P.; Arnold, Susanne M.; Awad, Mark M.; Gainor, Justin F.; Rao, Suman; Tsao, Anne S.; Zhou, Heng; Akala, Omobolaji O.; Chartash, Elliot; Nadal, Ernest
errShare
errSave
Results from KEYNOTE-B98: A phase 1b/2 study of pembrolizumab plus investigational agents in patients with anti-PD-(L)1-refractory extensive-stage small-cell lung cancer (ES-SCLC)
err2024-04-05
err0
PREAI
errNavarro, Alejandro; Ahn, Myung-Ju; Stevenson, James; Peled, Nir; Kutiel, Talia Shentzer; Huemer, Florian; Kim, Dong-Wan; Casulleras, Maria Jove; Khattak, Adnan; Kowalski, Dariusz; Leighl, Natasha B.; de Marinis, Filippo; Lips, Carolin; Niu, Jiaxin; Huang, Mo; Zhao, Bin; El-Osta, Hazem; Owonikoko, Taofeek
errShare
errSave
The interaction of mast cells with membranes from lung cancer cells induces the release of extracellular vesicles with a unique miRNA signature
err2023-12-06
err6
errOAAI
errShemesh, Rachel; Laufer-Geva, Smadar; Gorzalczany, Yaara; Anoze, Alaa; Sagi-Eisenberg, Ronit; Peled, Nir; Roisman, Laila C.
errShare
errSave
Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer
err2023-11-21
err9
errOAAI
errRoisman, Laila C.; Kian, Waleed; Anoze, Alaa; Fuchs, Vered; Spector, Maria; Steiner, Roee; Kassel, Levi; Rechnitzer, Gilad; Fried, Iris; Peled, Nir; Bogot, Naama R.
errShare
errSave
Amivantimab as a salvage strategy post TKI (osimertinib/mobocertinib) in EGFRm NSCLC
err2023-10-01
err0
PREAI
errKrayim, B. J.; Kian, W.; Heching, N.; Salhab, A. A. R.; Asna, N.; Kahala, D.; Roisman, L. C.; Peled, N.
errShare
errSave
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study
err2023-09-01
err12
PREAI
errPeled, Nir; Roisman, Laila C.; Levison, Esther; Dudnik, Julia; Chernomordikov, Elena; Heching, Norman; Dudnik, Elizabeth; Keren-Rosenberg, Shoshana; Nechushtan, Hovav; Salhab, Ayman; Hershkovitz, Dov; Tsuriel, Shlomo; Hannes, Victoria; Rotem, Ofer; Lazarev, Irina; Lichtenberg, Rachel; Granot, Inbal S.; Krayim, Bilal; Shalata, Walid; Levin, Daniel; Krutman, Yanay; Allen, Aaron M.; Blumenfeld, Philip; Lavrenkov, Konstantin; Kian, Waleed
errShare
errSave
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
err2023-06-01
err7
PREAI
errPrelaj, Arsela; Ganzinelli, Monica; Trovo, Francesco; Roisman, LailaC.; Pedrocchi, Alessandra Laura Giulia; Kosta, Sokol; Restelli, Marcello; Ambrosini, Emilia; Broggini, Massimo; Pravettoni, Gabriella; Monzani, Dario; Nuara, Alessandro; Amat, Ramon; Spathas, Nikos; Willis, Michael; Pearson, Alexander; Dolezal, James; Mazzeo, Laura; Sangaletti, Sabina; Correa, Ana Maria; Aguaron, Alfonso; Watermann, Iris; Popa, Crina; Raimondi, Giulia; Triulzi, Tiziana; Steurer, Stefan; Lo Russo, Giuseppe; Linardou, Helena; Peled, Nir; Felip, Enriqueta; Reck, Martin; Garassino, Marina Chiara
errShare
errSave
BRCA mutations detected by tumour next-generation sequencing in non-small cell lung cancer: impact on response to therapy and disease course
err2023-05-01
err2
errOAAI
errTschernichovsky, Roi; Averbuch, Itamar; Goldstein, Daniel Alex; Mutai, Raz; Dudnik, Elizabeth; Rotem, Ofer; Laufer-Geva, Smadar; Peled, Nir; Goldberg, Yael; Zer, Alona
errShare
errSave